As of 2025-11-06, the Relative Valuation of Canntab Therapeutics Ltd (PILL.CN) is (0.44) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.01 CAD, the upside of Canntab Therapeutics Ltd based on Relative Valuation is -8896.2%.
The range of the Relative Valuation is (0.35) - (0.53) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.1x - 6.1x | 5.1x |
| Forward P/E multiples | 4.1x - 6.1x | 5.1x |
| Fair Price | (0.35) - (0.53) | (0.44) |
| Upside | -7137.0% - -10655.5% | -8896.2% |
| Date | P/E |